Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


The Quest for Quality in Clinical Trials
The Quest for Quality in Clinical Trials

The Association of Clinical Research Professionals is focused on workforce training and development to ensure clinical trials are well designed, executed, and reported to move the science forward.

more
Time for Nashville to Get a Checkup
Time for Nashville to Get a Checkup

Nashville is past due for its routine checkup. A new countywide survey looks to assess health and well-being in Davidson County and set population health priorities for the future.

more
Study Tracks Impact of Neonatal Abstinence Syndrome on State Medicaid Programs 

In the United States, one infant is born every 15 minutes with withdrawal symptoms after being exposed to opioids before birth, according to a new study published in the journal Pediatrics.

more
Nashville Biosciences Launches
Nashville Biosciences Launches

In April, Vanderbilt University Medical Center announced the launch of a wholly owned subsidiary to advance drug and diagnostic discoveries.

more
Study Finds Adults in Poor Neighborhoods Have Higher Death Rates

Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans according to new research. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.

more
Novel Research Involving Cicadas Explores Way to Restore Silenced Voices
Novel Research Involving Cicadas Explores Way to Restore Silenced Voices

A swarm of cicadas that left thousands of insect carcasses across the Vanderbilt University campus in 2011 is leading to transinstitutional research at the Vanderbilt Institute for Surgery and Engineering (VISE) and Vanderbilt University Medical Center (VUMC) to develop a surgical planning tool to help restore speech for people with vocal fold paralysis.

more
Landmark Vanderbilt Studies Find IV Saline Less Beneficial Than Balanced Fluids for Patient Survival

Vanderbilt University Medical Center is encouraging its medical providers to stop using saline as intravenous fluid therapy for most patients, a change provoked by two companion landmark studies released today that are anticipated to improve patients' survival and decrease kidney complications.

more
Vanderbilt Investigators Discover New Compound to Starve Tumors

Researchers at Vanderbilt University Medical Center have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital nutrient glutamine.

more
Emergency Departments Not a Major Source of Opioid Prescriptions, New Study Shows

Opioid prescribing has increased 471 percent from 1996 to 2012, according to a new Annals of Emergency Medicine study, "Emergency Department Contribution to the Prescription Opioid Epidemic."

more
Vanderbilt Takes Investigational New Drug From Bench To Bedside
Vanderbilt Takes Investigational New Drug From Bench To Bedside

Patients with serious brain disorders such as Alzheimer's disease and schizophrenia could benefit from an investigational new drug (IND) that has received notification from the FDA that testing in humans may proceed after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.

more
FDA Approves Drug to Treat Duchenne Muscular Dystrophy
FDA Approves Drug to Treat Duchenne Muscular Dystrophy

On Feb. 9, the U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD).

more
Vanderbilt-led Trial Tests Whether Deep Brain Stimulations Slows Parkinson's Progression

A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson's disease in early-stage patients.

more
Vanderbilt's Department of Medicine Sees Dramatic Increase in Research Funding for 2016
Vanderbilt's Department of Medicine Sees Dramatic Increase in Research Funding for 2016

The Vanderbilt University School of Medicine has long been recognized as a national leader in biomedical research. Nowhere is this more evident than in the rise in federal research funding to faculty members in the school's Department of Medicine.

more
Experimental Insecticide Explodes Mosquitoes, Not Honeybees
Experimental Insecticide Explodes Mosquitoes, Not Honeybees

In a new study, Vanderbilt pharmacologist Jerod Denton, Ph.D., Ohio State entomologist Peter Piermarini, Ph.D., and colleagues report an experimental molecule that inhibits kidney function in mosquitoes and thus might provide a new way to control the deadliest animal on Earth.

more
Vanderbilt Research Explores Repositioning Existing Drugs to Prevent Epidemics
Vanderbilt Research Explores Repositioning Existing Drugs to Prevent Epidemics

Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than $1 billion to bring a new drug to market.

more
NIH Researchers Unveil Wound-Healing Role for Protein-Folding Gene in Mice
NIH Researchers Unveil Wound-Healing Role for Protein-Folding Gene in Mice

National Institutes of Health researchers have identified a novel role for a gene known as heat shock protein 60 (Hsp60), finding that it is critical in tissue regeneration and wound healing. The study found that topical treatment of an Hsp60-containing gel dramatically accelerates wound closure in a diabetic mouse model.

more
Wishes Granted

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a $3 million grant over the next three years to Vanderbilt-Ingram Cancer Center (VICC) investigators in support of VICC's drug discovery program.

more
New Vanderbilt Center to Focus on Addiction Research
New Vanderbilt Center to Focus on Addiction Research

Through the new Vanderbilt Center for Addiction Research (VCAR), researchers from diverse scientific disciplines are joining forces to define the molecular events that drive addictive behavior and ultimately to develop new treatments that can help people sustain long-term recovery.

more
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: